- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Acasti Pharma Inc.
Total 2378 results
-
Astellas Pharma Global Development, Inc.CompletedVasomotor SymptomsPoland, Spain, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Sweden, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.TerminatedChronic Tympanic Membrane PerforationUnited States
-
Astellas Pharma Global Development, Inc.TerminatedPharmacokinetics of Mirabegron | Overactive Bladder (OAB)Korea, Republic of, Russian Federation, Turkey
-
Astellas Pharma Global Development, Inc.CompletedOvarian Cancer | NSCLC | Solid Tumors | ESCCUnited States
-
Astellas Pharma Global Development, Inc.CompletedRenal Impaired | Gilteritinib | Normal Renal Function | Pharmacokinetics of ASP2215United States, Bulgaria
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.TerminatedHealthy ParticipantsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Metastatic Hormone-sensitive Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Withdrawn
-
Astellas Pharma Global Development, Inc.CompletedHealthy VolunteersUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia | Advanced Solid TumorsUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.Completed
-
Astellas Pharma Global Development, Inc.CompletedHealthy SubjectsUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid Tumors | Pharmacokinetics of 14C-labeled GilteritinibUnited States
-
Astellas Pharma Global Development, Inc.Terminated
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma Global Development, Inc.CompletedCoronary Artery Disease (CAD)United States, Peru, Argentina, Puerto Rico
-
Astellas Pharma Global Development, Inc.TerminatedCandidiasisPhilippines, United States, Canada, Israel, Romania, Greece, Turkey, Brazil, Bulgaria, Colombia, Hungary, Ukraine
-
Astellas Pharma Global Development, Inc.CompletedHealthy Volunteers | Pharmacokinetics of ASP015K | Food EffectUnited States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2409United States
-
Astellas Pharma Global Development, Inc.CompletedHealthy Subjects | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.CompletedRheumatoid Arthritis | Pharmacokinetics of ASP2408United States
-
Astellas Pharma Global Development, Inc.Completed
-
Nuvectis Pharma, Inc.RecruitingAdvanced Solid TumorUnited States, United Kingdom
-
Aneira Pharma, Inc.RecruitingHypotrichosisUnited States
-
Vincerx Pharma, Inc.RecruitingNeoplasmsAustralia, United States
-
Klus Pharma Inc.Recruiting
-
Kringle Pharma, Inc.Recruiting
-
Klus Pharma Inc.RecruitingBreast Cancer | Non-Small Cell Lung Cancer | Gastric Adenocarcinoma | Epithelial Ovarian Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Gastroesophageal Junction Adenocarcinoma | Small-Cell Lung CancerUnited States, China
-
OBI Pharma, IncRecruitingTriple Negative Breast CancerChina, Taiwan, United States, Korea, Republic of, Australia, Brazil, Hong Kong, Mexico, Russian Federation, South Africa, Ukraine, Peru, Poland
-
MEI Pharma, Inc.RecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United States
-
Astellas Pharma IncActive, not recruitingPrimary Mitochondrial MyopathyUnited States
-
Astellas Pharma IncCompletedGastric Cancer | Gastro-esophageal Junction (GEJ) CancerJapan
-
MEI Pharma, Inc.Active, not recruitingColorectal CancerUnited States
-
Inversago Pharma Inc.Active, not recruitingObesity | Metabolic SyndromeCanada
-
OBI Pharma, IncTerminatedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Taiwan
-
aTyr Pharma, Inc.CompletedLimb-Girdle Muscular Dystrophies | Facioscapulohumeral Muscular DystrophyUnited States, Denmark, France
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular Dystrophy (FSHD)United States, France, Italy
-
Astellas Pharma IncTerminatedDuchenne Muscular Dystrophy (DMD)United States
-
Ocuphire Pharma, Inc.CompletedOcular Hypertension | Open Angle GlaucomaUnited States
-
Ocuphire Pharma, Inc.CompletedMydriasis | DilationUnited States
-
aTyr Pharma, Inc.CompletedFacioscapulohumeral Muscular DystrophyUnited States, Italy, Netherlands
-
Sinew Pharma Inc.Completed
-
Ocuphire Pharma, Inc.Active, not recruiting
-
Yuyu Pharma, Inc.Active, not recruiting
-
Astellas Pharma IncCompletedLocally Advanced (Unresectable) or Metastatic Solid Tumor MalignanciesJapan